Correction: DJ-1-dependent regulation of oxidative stress in the Retinal Pigment Epithelium (RPE) (PLoS ONE (2013) 8:7 (e67983) DOI: 10.1371/journal.pone.0067983);DJ-1-Dependent Regulation of Oxidative Stress in the Retinal Pigment Epithelium (RPE)

PLoS ONE

Volumn 8, Issue 7, 2013, Pages

  Shadrach, Karen G ^a   Rayborn, Mary E ^a   Hollyfield, Joe G ^a   Bonilha, Vera L ^a  

^a CLEVELAND CLINIC LERNER COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; DJ 1 PROTEIN; HYDROGEN PEROXIDE;

AMINO ACID COMPOSITION; ANIMAL CELL; ARTICLE; BIOSYNTHESIS; BRUCH MEMBRANE; CELL NUCLEUS; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOPLASM; DOSE RESPONSE; GENE FUNCTION; GENE LOCATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; MITOCHONDRION; MOLECULAR PATHOLOGY; MOUSE; NONHUMAN; OXIDATIVE STRESS; PIGMENT EPITHELIUM; RETINA MACULA AGE RELATED DEGENERATION;

EID: 84879776164     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0185834     Document Type: Erratum

References (111)

1. Bok D (1993) The retinal pigment epithelium: a versatile partner in vision. J Cell Sci Suppl 17: 189-195.
2. Liang FQ, Godley BF, (2003) Oxidative stress-induced mitochondrial DNA damage in human retinal pigment epithelial cells: a possible mechanism for RPE aging and age-related macular degeneration. Exp Eye Res 76: 397-403.
3. Tanito M, Brush RS, Elliott MH, Wicker LD, Henry KR, et al. (2009) High levels of retinal membrane docosahexaenoic acid increase susceptibility to stress-induced degeneration. J Lipid Res 50: 807-819.
4. Miceli MV, Liles MR, Newsome DA, (1994) Evaluation of oxidative processes in human pigment epithelial cells associated with retinal outer segment phagocytosis. Exp Cell Res 214: 242-249.
5. Tate DJ Jr, Miceli MV, Newsome DA, (1995) Phagocytosis and H2O2 induce catalase and metallothionein gene expression in human retinal pigment epithelial cells. Invest Ophthalmol Vis Sci 36: 1271-1279.
6. Beatty S, Koh H, Phil M, Henson D, Boulton M, (2000) The role of oxidative stress in the pathogenesis of age-related macular degeneration. Surv Ophthalmol 45: 115-134.
7. Drobek-Slowik M, Karczewicz D, Safranow K, (2007) [The potential role of oxidative stress in the pathogenesis of the age-related macular degeneration (AMD)]. Postepy Hig Med Dosw (Online) 61: 28-37.
8. Bonifati V, Rizzu P, Squitieri F, Krieger E, Vanacore N, et al. (2003) DJ-1(PARK7), a novel gene for autosomal recessive, early onset parkinsonism. Neurol Sci 24: 159-160.
9. Nagakubo D, Taira T, Kitaura H, Ikeda M, Tamai K, et al. (1997) DJ-1, a novel oncogene which transforms mouse NIH3T3 cells in cooperation with ras. Biochem Biophys Res Commun 231: 509-513.
10. Hod Y, (2004) Differential control of apoptosis by DJ-1 in prostate benign and cancer cells. J Cell Biochem 92: 1221-1233.
11. Gao X, Ning Y, (2011) Cancer and Parkinson's disease: the odd couple. Drugs Today (Barc) 47: 215-222.
12. Hod Y, Pentyala SN, Whyard TC, El-Maghrabi MR, (1999) Identification and characterization of a novel protein that regulates RNA-protein interaction. J Cell Biochem 72: 435-444.
13. Shinbo Y, Taira T, Niki T, Iguchi-Ariga SM, Ariga H, (2005) DJ-1 restores p53 transcription activity inhibited by Topors/p53BP3. Int J Oncol 26: 641-648.
14. Zhong N, Kim CY, Rizzu P, Geula C, Porter DR, et al. (2006) DJ-1 transcriptionally up-regulates the human tyrosine hydroxylase by inhibiting the sumoylation of pyrimidine tract-binding protein-associated splicing factor. J Biol Chem 281: 20940-20948.
15. Clements CM, McNally RS, Conti BJ, Mak TW, Ting JP, (2006) DJ-1, a cancer- and Parkinson's disease-associated protein, stabilizes the antioxidant transcriptional master regulator Nrf2. Proc Natl Acad Sci U S A 103: 15091-15096.
16. Takahashi K, Taira T, Niki T, Seino C, Iguchi-Ariga SM, et al. (2001) DJ-1 positively regulates the androgen receptor by impairing the binding of PIASx alpha to the receptor. J Biol Chem 276: 37556-37563.
17. Shendelman S, Jonason A, Martinat C, Leete T, Abeliovich A, (2004) DJ-1 is a redox-dependent molecular chaperone that inhibits alpha-synuclein aggregate formation. PLoS Biol 2: e362.
18. Zhou W, Zhu M, Wilson MA, Petsko GA, Fink AL, (2006) The oxidation state of DJ-1 regulates its chaperone activity toward alpha-synuclein. J Mol Biol 356: 1036-1048.
19. Yoshida K, Sato Y, Yoshiike M, Nozawa S, Ariga H, et al. (2003) Immunocytochemical localization of DJ-1 in human male reproductive tissue. Mol Reprod Dev 66: 391-397.
20. Mitsumoto A, Nakagawa Y, (2001) DJ-1 is an indicator for endogenous reactive oxygen species elicited by endotoxin. Free Radic Res 35: 885-893.
21. Taira T, Saito Y, Niki T, Iguchi-Ariga SM, Takahashi K, et al. (2004) DJ-1 has a role in antioxidative stress to prevent cell death. EMBO Rep 5: 213-218.
22. Martinat C, Shendelman S, Jonason A, Leete T, Beal MF, et al. (2004) Sensitivity to oxidative stress in DJ-1-deficient dopamine neurons: an ES- derived cell model of primary Parkinsonism. PLoS Biol 2: e327.
23. Canet-Aviles RM, Wilson MA, Miller DW, Ahmad R, McLendon C, et al. (2004) The Parkinson's disease protein DJ-1 is neuroprotective due to cysteine-sulfinic acid-driven mitochondrial localization. Proc Natl Acad Sci U S A 101: 9103-9108.
24. Takahashi-Niki K, Niki T, Taira T, Iguchi-Ariga SM, Ariga H, (2004) Reduced anti-oxidative stress activities of DJ-1 mutants found in Parkinson's disease patients. Biochem Biophys Res Commun 320: 389-397.
25. Kim RH, Smith PD, Aleyasin H, Hayley S, Mount MP, et al. (2005) Hypersensitivity of DJ-1-deficient mice to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyrindine (MPTP) and oxidative stress. Proc Natl Acad Sci U S A 102: 5215-5220.
26. Park J, Kim SY, Cha GH, Lee SB, Kim S, et al. (2005) Drosophila DJ-1 mutants show oxidative stress-sensitive locomotive dysfunction. Gene 361: 133-139.
27. Choi J, Sullards MC, Olzmann JA, Rees HD, Weintraub ST, et al. (2006) Oxidative damage of DJ-1 is linked to sporadic Parkinson and Alzheimer diseases. J Biol Chem 281: 10816-10824.
28. Meulener MC, Xu K, Thomson L, Ischiropoulos H, Bonini NM, (2006) Mutational analysis of DJ-1 in Drosophila implicates functional inactivation by oxidative damage and aging. Proc Natl Acad Sci U S A 103: 12517-12522.
29. Kahle PJ, Waak J, Gasser T, (2009) DJ-1 and prevention of oxidative stress in Parkinson's disease and other age-related disorders. Free Radic Biol Med 47: 1354-1361.
30. Mitsumoto A, Nakagawa Y, Takeuchi A, Okawa K, Iwamatsu A, et al. (2001) Oxidized forms of peroxiredoxins and DJ-1 on two-dimensional gels increased in response to sublethal levels of paraquat. Free Radic Res 35: 301-310.
31. Zhou W, Freed CR, (2005) DJ-1 up-regulates glutathione synthesis during oxidative stress and inhibits A53T alpha-synuclein toxicity. J Biol Chem 280: 43150-43158.
32. Bonifati V, Rizzu P, van Baren MJ, Schaap O, Breedveld GJ, et al. (2003) Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism. Science 299: 256-259.
33. Junn E, Taniguchi H, Jeong BS, Zhao X, Ichijo H, et al. (2005) Interaction of DJ-1 with Daxx inhibits apoptosis signal-regulating kinase 1 activity and cell death. Proc Natl Acad Sci U S A 102: 9691-9696.
34. Xu J, Zhong N, Wang H, Elias JE, Kim CY, et al. (2005) The Parkinson's disease-associated DJ-1 protein is a transcriptional co-activator that protects against neuronal apoptosis. Hum Mol Genet 14: 1231-1241.
35. Malhotra D, Thimmulappa R, Navas-Acien A, Sandford A, Elliott M, et al. (2008) Decline in NRF2-regulated antioxidants in chronic obstructive pulmonary disease lungs due to loss of its positive regulator, DJ-1. Am J Respir Crit Care Med 178: 592-604.
36. Yokota T, Sugawara K, Ito K, Takahashi R, Ariga H, et al. (2003) Down regulation of DJ-1 enhances cell death by oxidative stress, ER stress, and proteasome inhibition. Biochem Biophys Res Commun 312: 1342-1348.
37. van der Brug MP, Blackinton J, Chandran J, Hao LY, Lal A, et al. (2008) RNA binding activity of the recessive parkinsonism protein DJ-1 supports involvement in multiple cellular pathways. Proc Natl Acad Sci U S A 105: 10244-10249.
38. Ottolini D, Cali T, Negro A, Brini M (2013) The Parkinson disease-related protein DJ-1 counteracts mitochondrial impairment induced by the tumour suppressor protein p53 by enhancing endoplasmic reticulum-mitochondria tethering. Hum Mol Genet.
39. Larsen NJ, Ambrosi G, Mullett SJ, Berman SB, Hinkle DA, (2011) DJ-1 knock-down impairs astrocyte mitochondrial function. Neuroscience 196: 251-264.
40. Mullett SJ, Hinkle DA, (2011) DJ-1 deficiency in astrocytes selectively enhances mitochondrial Complex I inhibitor-induced neurotoxicity. J Neurochem 117: 375-387.
41. Gonzalez-Polo R, Niso-Santano M, Moran JM, Ortiz-Ortiz MA, Bravo-San Pedro JM, et al. (2009) Silencing DJ-1 reveals its contribution in paraquat-induced autophagy. J Neurochem 109: 889-898.
42. Yamashita S, Mori A, Kimura E, Mita S, Maeda Y, et al. (2010) DJ-1 forms complexes with mutant SOD1 and ameliorates its toxicity. J Neurochem 113: 860-870.
43. Lev N, Ickowicz D, Barhum Y, Lev S, Melamed E, et al. (2009) DJ-1 protects against dopamine toxicity. J Neural Transm 116: 151-160.
44. Gu X, Neric NJ, Crabb JS, Crabb JW, Bhattacharya SK, et al. (2012) Age-related changes in the retinal pigment epithelium (RPE). PLoS One 7: e38673.
45. Chen M, Muckersie E, Robertson M, Fraczek M, Forrester JV, et al. (2008) Characterization of a spontaneous mouse retinal pigment epithelial cell line B6-RPE07. Invest Ophthalmol Vis Sci 49: 3699-3706.
46. Bonilha VL, Finnemann SC, Rodriguez-Boulan E, (1999) Ezrin promotes morphogenesis of apical microvilli and basal infoldings in retinal pigment epithelium. J Cell Biol 147: 1533-1548.
47. Kinumi T, Kimata J, Taira T, Ariga H, Niki E, (2004) Cysteine-106 of DJ-1 is the most sensitive cysteine residue to hydrogen peroxide-mediated oxidation in vivo in human umbilical vein endothelial cells. Biochem Biophys Res Commun 317: 722-728.
48. Wilson MA, (2011) The role of cysteine oxidation in DJ-1 function and dysfunction. Antioxid Redox Signal 15: 111-122.
49. Ooe H, Iguchi-Ariga SM, Ariga H, (2006) Establishment of specific antibodies that recognize C106-oxidized DJ-1. Neurosci Lett 404: 166-169.
50. Zhang L, Shimoji M, Thomas B, Moore DJ, Yu SW, et al. (2005) Mitochondrial localization of the Parkinson's disease related protein DJ-1: implications for pathogenesis. Hum Mol Genet 14: 2063-2073.
51. Ooe H, Taira T, Iguchi-Ariga SM, Ariga H, (2005) Induction of reactive oxygen species by bisphenol A and abrogation of bisphenol A-induced cell injury by DJ-1. Toxicol Sci 88: 114-126.
52. Lev N, Ickowicz D, Melamed E, Offen D, (2008) Oxidative insults induce DJ-1 upregulation and redistribution: implications for neuroprotection. Neurotoxicology 29: 397-405.
53. George S, Mok SS, Nurjono M, Ayton S, Finkelstein DI, et al. (2010) alpha-Synuclein transgenic mice reveal compensatory increases in Parkinson's disease-associated proteins DJ-1 and parkin and have enhanced alpha-synuclein and PINK1 levels after rotenone treatment. J Mol Neurosci 42: 243-254.
54. Inberg A, Linial M, (2010) Protection of pancreatic beta-cells from various stress conditions is mediated by DJ-1. J Biol Chem 285: 25686-25698.
55. Knobbe CB, Revett TJ, Bai Y, Chow V, Jeon AH, et al. (2011) Choice of biological source material supersedes oxidative stress in its influence on DJ-1 in vivo interactions with Hsp90. J Proteome Res 10: 4388-4404.
56. Bitar MS, Liu C, Ziaei A, Chen Y, Schmedt T, et al. (2012) Decline in DJ-1 and decreased nuclear translocation of Nrf2 in Fuchs endothelial corneal dystrophy. Invest Ophthalmol Vis Sci 53: 5806-5813.
57. Joselin AP, Hewitt SJ, Callaghan SM, Kim RH, Chung YH, et al. (2012) ROS-dependent regulation of Parkin and DJ-1 localization during oxidative stress in neurons. Hum Mol Genet 21: 4888-4903.
58. Saito Y, Hamakubo T, Yoshida Y, Ogawa Y, Hara Y, et al. (2009) Preparation and application of monoclonal antibodies against oxidized DJ-1. Significant elevation of oxidized DJ-1 in erythrocytes of early-stage Parkinson disease patients. Neurosci Lett 465: 1-5.
59. Akazawa YO, Saito Y, Hamakubo T, Masuo Y, Yoshida Y, et al. (2010) Elevation of oxidized DJ-1 in the brain and erythrocytes of Parkinson disease model animals. Neurosci Lett 483: 201-205.
60. Kitamura Y, Watanabe S, Taguchi M, Takagi K, Kawata T, et al. (2011) Neuroprotective effect of a new DJ-1-binding compound against neurodegeneration in Parkinson's disease and stroke model rats. Mol Neurodegener 6: 48.
61. Hulleman JD, Mirzaei H, Guigard E, Taylor KL, Ray SS, et al. (2007) Destabilization of DJ-1 by familial substitution and oxidative modifications: implications for Parkinson's disease. Biochemistry 46: 5776-5789.
62. Blackinton J, Ahmad R, Miller DW, van der Brug MP, Canet-Aviles RM, et al. (2005) Effects of DJ-1 mutations and polymorphisms on protein stability and subcellular localization. Brain Res Mol Brain Res 134: 76-83.
63. Gorner K, Holtorf E, Waak J, Pham TT, Vogt-Weisenhorn DM, et al. (2007) Structural determinants of the C-terminal helix-kink-helix motif essential for protein stability and survival promoting activity of DJ-1. J Biol Chem 282: 13680-13691.
64. Lin J, Prahlad J, Wilson MA, (2012) Conservation of oxidative protein stabilization in an insect homologue of parkinsonism-associated protein DJ-1. Biochemistry 51: 3799-3807.
65. Blackinton J, Lakshminarasimhan M, Thomas KJ, Ahmad R, Greggio E, et al. (2009) Formation of a stabilized cysteine sulfinic acid is critical for the mitochondrial function of the parkinsonism protein DJ-1. J Biol Chem 284: 6476-6485.
66. Kim SJ, Park YJ, Oh YJ, (2012) Proteomic analysis reveals a protective role for DJ-1 during 6-hydroxydopamine-induced cell death. Biochem Biophys Res Commun 422: 8-14.
67. Jeong HJ, Kim DW, Kim MJ, Woo SJ, Kim HR, et al. (2012) Protective effects of transduced Tat-DJ-1 protein against oxidative stress and ischemic brain injury. Exp Mol Med 44: 586-593.
68. Robert G, Puissant A, Dufies M, Marchetti S, Jacquel A, et al. (2012) The caspase 6 derived N-terminal fragment of DJ-1 promotes apoptosis via increased ROS production. Cell Death Differ 19: 1769-1778.
69. Yu HH, Xu Q, Chen HP, Wang S, Huang XS, et al. (2013) Stable overexpression of DJ-1 protects H9c2 cells against oxidative stress under a hypoxia condition. Cell Biochem Funct.
70. Nowak JZ, (2006) Age-related macular degeneration (AMD): pathogenesis and therapy. Pharmacol Rep 58: 353-363.
71. Ding X, Patel M, Chan CC, (2009) Molecular pathology of age-related macular degeneration. Prog Retin Eye Res 28: 1-18.
72. Kinnunen K, Petrovski G, Moe MC, Berta A, Kaarniranta K, (2012) Molecular mechanisms of retinal pigment epithelium damage and development of age-related macular degeneration. Acta Ophthalmol 90: 299-309.
73. Mohan R, Sivak J, Ashton P, Russo LA, Pham BQ, et al. (2000) Curcuminoids inhibit the angiogenic response stimulated by fibroblast growth factor-2, including expression of matrix metalloproteinase gelatinase B. J Biol Chem. 275: 10405-10412.
74. Schutt F, Volcker HE, Dithmar S, (2007) [N-acetylcysteine improves lysosomal function and enhances the degradation of photoreceptor outer segments in cultured RPE cells]. Klin Monbl Augenheilkd 224: 580-584.
75. Chan CM, Huang JH, Lin HH, Chiang HS, Chen BH, et al. (2008) Protective effects of (-)-epigallocatechin gallate on UVA-induced damage in ARPE19 cells. Mol Vis 14: 2528-2534.
76. Cao GF, Liu Y, Yang W, Wan J, Yao J, et al. (2011) Rapamycin sensitive mTOR activation mediates nerve growth factor (NGF) induced cell migration and pro-survival effects against hydrogen peroxide in retinal pigment epithelial cells. Biochem Biophys Res Commun 414: 499-505.
77. Chong EW, Wong TY, Kreis AJ, Simpson JA, Guymer RH, (2007) Dietary antioxidants and primary prevention of age related macular degeneration: systematic review and meta-analysis. BMJ 335: 755.
78. Parisi V, Tedeschi M, Gallinaro G, Varano M, Saviano S, et al. (2008) Carotenoids and antioxidants in age-related maculopathy italian study: multifocal electroretinogram modifications after 1 year. Ophthalmology 115: 324-333 e322.
79. Bandopadhyay R, Kingsbury AE, Cookson MR, Reid AR, Evans IM, et al. (2004) The expression of DJ-1 (PARK7) in normal human CNS and idiopathic Parkinson's disease. Brain 127: 420-430.
80. Jarrett SG, Lin H, Godley BF, Boulton ME, (2008) Mitochondrial DNA damage and its potential role in retinal degeneration. Prog Retin Eye Res 27: 596-607.
81. Turrens JF, (2003) Mitochondrial formation of reactive oxygen species. J Physiol 552: 335-344.
82. Shabalina IG, Nedergaard J, (2011) Mitochondrial ('mild') uncoupling and ROS production: physiologically relevant or not? Biochem Soc Trans 39: 1305-1309.
83. Santos JH, Hunakova L, Chen Y, Bortner C, Van Houten B, (2003) Cell sorting experiments link persistent mitochondrial DNA damage with loss of mitochondrial membrane potential and apoptotic cell death. J Biol Chem 278: 1728-1734.
84. Feher J, Kovacs I, Artico M, Cavallotti C, Papale A, et al. (2006) Mitochondrial alterations of retinal pigment epithelium in age-related macular degeneration. Neurobiol Aging 27: 983-993.
85. Nordgaard CL, Berg KM, Kapphahn RJ, Reilly C, Feng X, et al. (2006) Proteomics of the retinal pigment epithelium reveals altered protein expression at progressive stages of age-related macular degeneration. Invest Ophthalmol Vis Sci 47: 815-822.
86. Nordgaard CL, Karunadharma PP, Feng X, Olsen TW, Ferrington DA, (2008) Mitochondrial proteomics of the retinal pigment epithelium at progressive stages of age-related macular degeneration. Invest Ophthalmol Vis Sci 49: 2848-2855.
87. SanGiovanni JP, Arking DE, Iyengar SK, Elashoff M, Clemons TE, et al. (2009) Mitochondrial DNA variants of respiratory complex I that uniquely characterize haplogroup T2 are associated with increased risk of age-related macular degeneration. PLoS One 4: e5508.
88. Kenney MC, Atilano SR, Boyer D, Chwa M, Chak G, et al. (2010) Characterization of retinal and blood mitochondrial DNA from age-related macular degeneration patients. Invest Ophthalmol Vis Sci 51: 4289-4297.
89. Mueller EE, Schaier E, Brunner SM, Eder W, Mayr JA, et al. (2012) Mitochondrial haplogroups and control region polymorphisms in age-related macular degeneration: a case-control study. PLoS One 7: e30874.
90. Stenirri S, Santambrogio P, Setaccioli M, Erba BG, Pia Manitto M, et al. (2012) Study of FTMT and ABCA4 genes in a patient affected by age-related macular degeneration: identification and analysis of new mutations. Clin Chem Lab Med 50: 1021-1029.
91. Blasiak J, Glowacki S, Kauppinen A, Kaarniranta K, (2013) Mitochondrial and nuclear DNA damage and repair in age-related macular degeneration. Int J Mol Sci 14: 2996-3010.
92. Kenney MC, Hertzog D, Chak G, Atilano SR, Khatibi N, et al. (2013) Mitochondrial DNA haplogroups confer differences in risk for age-related macular degeneration: a case control study. BMC Med Genet 14: 4.
93. Crabb JW, Miyagi M, Gu X, Shadrach K, West KA, et al. (2002) Drusen proteome analysis: an approach to the etiology of age-related macular degeneration. Proc Natl Acad Sci U S A 99: 14682-14687.
94. Bando H, Shadrach KG, Rayborn ME, Crabb JW, Hollyfield JG, (2007) Clathrin and adaptin accumulation in drusen, Bruch's membrane and choroid in AMD and non-AMD donor eyes. Exp Eye Res 84: 135-142.
95. Hageman GS, Mullins RF, Russell SR, Johnson LV, Anderson DH, (1999) Vitronectin is a constituent of ocular drusen and the vitronectin gene is expressed in human retinal pigmented epithelial cells. FASEB J 13: 477-484.
96. Mullins RF, Russell SR, Anderson DH, Hageman GS, (2000) Drusen associated with aging and age-related macular degeneration contain proteins common to extracellular deposits associated with atherosclerosis, elastosis, amyloidosis, and dense deposit disease. FASEB J 14: 835-846.
97. Anderson DH, Ozaki S, Nealon M, Neitz J, Mullins RF, et al. (2001) Local cellular sources of apolipoprotein E in the human retina and retinal pigmented epithelium: implications for the process of drusen formation. Am J Ophthalmol 131: 767-781.
98. Malek G, Li CM, Guidry C, Medeiros NE, Curcio CA, (2003) Apolipoprotein B in cholesterol-containing drusen and basal deposits of human eyes with age-related maculopathy. Am J Pathol 162: 413-425.
99. Shimwell NJ, Ward DG, Mohri Y, Mohri T, Pallan L, et al. (2012) Macrophage migration inhibitory factor and DJ-1 in gastric cancer: differences between high-incidence and low-incidence areas. Br J Cancer 107: 1595-1601.
100. Lisitskaia KV, Eremina LS, Ivanov AV, Kovaleva MA, Okhrits VE, et al. (2011) [Study of Dj-1 protein in tissue specimens, cultured cells and serum of prostate cancer patients]. Biomed Khim 57: 392-401.
101. Chen Y, Kang M, Lu W, Guo Q, Zhang B, et al. (2012) DJ-1, a novel biomarker and a selected target gene for overcoming chemoresistance in pancreatic cancer. J Cancer Res Clin Oncol 138: 1463-1474.
102. Zeng HZ, Qu YQ, Zhang WJ, Xiu B, Deng AM, et al. (2011) Proteomic Analysis Identified DJ-1 as a Cisplatin Resistant Marker in Non-Small Cell Lung Cancer. Int J Mol Sci 12: 3489-3499.
103. Pardo M, Garcia A, Thomas B, Pineiro A, Akoulitchev A, et al. (2006) The characterization of the invasion phenotype of uveal melanoma tumour cells shows the presence of MUC18 and HMG-1 metastasis markers and leads to the identification of DJ-1 as a potential serum biomarker. Int J Cancer 119: 1014-1022.
104. Oda M, Makita M, Iwaya K, Akiyama F, Kohno N, et al. (2012) High levels of DJ-1 protein in nipple fluid of patients with breast cancer. Cancer Sci 103: 1172-1176.
105. Hong Z, Shi M, Chung KA, Quinn JF, Peskind ER, et al. (2010) DJ-1 and alpha-synuclein in human cerebrospinal fluid as biomarkers of Parkinson's disease. Brain 133: 713-726.
106. Shi M, Furay AR, Sossi V, Aasly JO, Armaly J, et al. (2012) DJ-1 and alphaSYN in LRRK2 CSF do not correlate with striatal dopaminergic function. Neurobiol Aging 33: 836 e835-837.
107. Salvesen L, Bech S, Lokkegaard A, Hjermind LE, Nielsen JE, et al. (2012) The DJ-1 concentration in cerebrospinal fluid does not differentiate among Parkinsonian syndromes. Parkinsonism Relat Disord 18: 899-901.
108. Abdalla MA, Haj-Ahmad Y, (2012) Promising Urinary Protein Biomarkers for the Early Detection of Hepatocellular Carcinoma among High-Risk Hepatitis C Virus Egyptian Patients. J Cancer 3: 390-403.
109. Davis AA, Bernstein PS, Bok D, Turner J, Nachtigal M, et al. (1995) A human retinal pigment epithelial cell line that retains epithelial characteristics after prolonged culture. Invest Ophthalmol Vis Sci 36: 955-964.
110. Nandrot EF, Kim Y, Brodie SE, Huang X, Sheppard D, et al. (2004) Loss of synchronized retinal phagocytosis and age-related blindness in mice lacking alphavbeta5 integrin. J Exp Med 200: 1539-1545.
111. Bonilha VL, Shadrach KG, Rayborn ME, Li Y, Pauer GJ, et al. (2013) Retinal deimination and PAD2 levels in retinas from donors with age-related macular degeneration (AMD). Exp Eye Res 111C: 71-78.